Therapy News and Research

RSS

Researchers identify microRNA-155 as prognostic marker, treatment target in patients with AML

A study has identified microRNA-155 as a new independent prognostic marker and treatment target in patients with acute myeloid leukemia that has normal-looking chromosomes under the microscope (that is, cytogenetically normal acute myeloid leukemia, or CN-AML).

14 May 2013

Tel Aviv University researchers invent a method for repairing damaged peripheral nerves

Some parts of the body, like the liver, can regenerate themselves after damage. But others, such as our nervous system, are considered either irreparable or slow to recover, leaving thousands with a lifetime of pain, limited mobility, or even paralysis.

14 May 2013

FDA grants priority review for Janssen's simeprevir

Medivir AB today announces that the U.S. Food and Drug Administration has granted Priority Review to the New Drug Application by Janssen for simeprevir (TMC435), an investigational NS3/4A protease inhibitor administered as a 150 mg capsule once daily with pegylated interferon and ribavirin for the treatment of genotype 1 chronic hepatitis C in adult patients with compensated liver disease.

14 May 2013

Sorin Group receives FDA approval for SMARTVIEW remote monitoring solution

Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, today announced it received FDA approval for and is beginning the U.S. launch of the SMARTVIEW remote monitoring solution for patients with implanted cardiac rhythm management devices.

13 May 2013

New NIH funding to help researchers explore promising new approaches to cure stroke

Dr. Gregory Bix, Paul G. Blazer J. Professor of Stroke Research in the University of Kentucky Sanders-Brown Center on Aging and the UK departments of Anatomy and Neurobiology and Neurology, has received funding of $224,416 from the National Institutes of Health, to further study of stroke recovery.

13 May 2013

Exposure to Agent Orange may increase risk of developing lethal forms of prostate cancer

A new analysis has found a link between exposure to Agent Orange and lethal forms of prostate cancer among US Veterans. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings suggest that Agent Orange exposure history should be incorporated into prostate screening decisions for Veterans.

13 May 2013

New challenges to military medicine

Better body armor and rapid aeromedical evacuations enable American service members to survive blasts that would have proved fatal in Vietnam or even the first Gulf War, but they pose new challenges to military medicine - how to deal with the excruciating pain of injuries, especially severe burns from IED blasts that body armor can't protect.

13 May 2013

TYRX's AIGISRx Antibacterial Envelope reduces CIED infection rates by more than 90%

Use of TYRX, Inc.'s AIGISRx- Antibacterial Envelope reduced major infection rates by more than 90% in patients undergoing Cardiovascular Implantable Electronic Device replacement procedures compared to similar high-risk cohorts, according to the CITADEL & CENTURION clinical study results presented on Saturday at the Late Breaking Clinical Trials session at Heart Rhythm 2013, the Heart Rhythm Society's 34th Annual Scientific Sessions.

13 May 2013

Research: Patients with chronic pain should be evaluated for anxiety disorders

Patients coping with chronic pain should also be evaluated for anxiety disorders, according to new research published in General Hospital Psychiatry.

13 May 2013

UNM Cancer Center to participate in Phase 3 clinical trial of novel treatment for men with prostate cancer

The University of New Mexico Cancer Center is among a few select institutions nationwide participating in a Phase 3 clinical trial studying a novel treatment for men with newly diagnosed, localized prostate cancer.

13 May 2013

Researchers identify clue to explain the reversible memory loss caused by statins

The U.S. Food and Drug Administration and physicians continue to document that some patients experience fuzzy thinking and memory loss while taking statins, a class of global top-selling cholesterol-lowering drugs.

13 May 2013

Study shows patient satisfaction from a pharmacy program

As hospitals look for ways to improve patient satisfaction and boost their Medicare reimbursement, a Henry Ford Hospital study found that an inpatient pharmacist-directed anticoagulation service might be an unexpected opportunity.

13 May 2013

Breo Ellipta gets FDA approval for treatment of airflow obstruction in patients with COPD

The U.S. Food and Drug Administration today approved Breo Ellipta (fluticasone furoate and vilanterol inhalation powder) for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, including chronic bronchitis and/or emphysema.

13 May 2013

John Theurer to host 9th annual neuro-oncology symposium on May 17

John Theurer Cancer Center at Hackensack University Medical Center, one of the nation's top 50 cancer centers, will host its Ninth Annual Neuro-Oncology Symposium on Friday, May 17th from 8:00am-1:00pm. Experts from MD Anderson, Memorial Sloan Kettering Cancer Center, Penn State Milton S. Hershey Medical Center, and the Cleveland Clinic will present advances in multidisciplinary care for cancers of the central nervous system.

10 May 2013

Mouse study shows leukemia halts accumulation of toxic proteins linked to Parkinson's disease

Researchers at Georgetown University Medical Center have used tiny doses of a leukemia drug to halt accumulation of toxic proteins linked to Parkinson's disease in the brains of mice. This finding provides the basis to plan a clinical trial in humans to study the effects.

10 May 2013

Operating without interrupting warfarin treatment during cardiac device surgery reduces hematomas

A new Canadian study shows that operating without interrupting warfarin treatment at the time of cardiac device surgery is safe and markedly reduces the incidence of clinically significant hematomas compared to the current standard of care.

10 May 2013

Severe anorexia nervosa improves with modification of standard goals, treatment methods

A new, multinational randomized clinical trial has found that patients with severe and enduring anorexia nervosa will not only stick with treatments but also make significant improvements with just a slight modification of the standard goals and methods of treatment.

10 May 2013

Children on dialysis for severe kidney disease have reduce risk of death

Children on dialysis for severe kidney disease have a dramatically reduced risk of death compared to 20 years ago, a new study shows. The findings, from a study led by Dr. Bethany Foster from the Research Institute of the McGill University Health Centre (RI-MUHC), are very encouraging for children with end-stage kidney disease.

10 May 2013

Uroplasty highlights results of STEP Study on PTNS treatments for overactive bladder

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today highlighted the 3-year results of the STEP Study on percutaneous tibial nerve stimulation treatments for overactive bladder using Uroplasty's Urgent PC Neuromodulation System.

10 May 2013

Sunnybrook Health Sciences Centre signs research agreement to evaluate MRI-guided radiation therapy

Elekta and Royal Philips Electronics announced today that Sunnybrook Health Sciences Centre (Toronto, Canada) will join their growing consortium to validate the clinical potential of MRI-guided radiation therapy.

From Elekta 10 May 2013

Therapy News and Research

Researchers identify microRNA-155 as prognostic marker, treatment target in patients with AML

Tel Aviv University researchers invent a method for repairing damaged peripheral nerves

FDA grants priority review for Janssen's simeprevir

Sorin Group receives FDA approval for SMARTVIEW remote monitoring solution

New NIH funding to help researchers explore promising new approaches to cure stroke

Exposure to Agent Orange may increase risk of developing lethal forms of prostate cancer

New challenges to military medicine

TYRX's AIGISRx Antibacterial Envelope reduces CIED infection rates by more than 90%

Research: Patients with chronic pain should be evaluated for anxiety disorders

UNM Cancer Center to participate in Phase 3 clinical trial of novel treatment for men with prostate cancer

Researchers identify clue to explain the reversible memory loss caused by statins

Study shows patient satisfaction from a pharmacy program

Breo Ellipta gets FDA approval for treatment of airflow obstruction in patients with COPD

John Theurer to host 9th annual neuro-oncology symposium on May 17

Mouse study shows leukemia halts accumulation of toxic proteins linked to Parkinson's disease

Operating without interrupting warfarin treatment during cardiac device surgery reduces hematomas

Severe anorexia nervosa improves with modification of standard goals, treatment methods

Children on dialysis for severe kidney disease have reduce risk of death

Uroplasty highlights results of STEP Study on PTNS treatments for overactive bladder

Sunnybrook Health Sciences Centre signs research agreement to evaluate MRI-guided radiation therapy

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News